In
this webinar, you will understand the realities that
Swiss Medtech and Biopharma companies are facing when entering in the Chinese
market. What are the market needs, what are the prerequisite, the expected
time for registration or the mandatory to have a subsidiary in China to
distribute on the market? Our top-level MedTech and Biopharma experts as well
as entrepreneur with strong experiences will answer these questions and help
you to get the gist of this potential market for
Swiss industries.
To make this webinar interactive, participants will be able to ask questions to the speakers after their presentation.
Participation fee: free of charge
Programm Details
Urs Mattes
MedTech Consultant with 20+ years of experience in China and Asia
Michael Zhang
Regulatory Affairs Franchise Leader/Global Life Science Consultant at Widler & Schiemann Ltd.
Edouard Goetgheluck
Senior VP Sales Ous at Spineart SA
Moderator: Zhen Xiao
CEO at Swiss Centers China
Host: Aline Ballaman-Garibian
Board Member at SCCC Romandie Chapter